Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth

Jennifer M. Bingham, Jennifer Stanislaw, Terri Warholak, Nicole Scovis, David R. Axon, Jacques Turgeon and Srujitha Marupuru
Additional contact information
Jennifer M. Bingham: Tabula Rasa HealthCare, Tucson, AZ 85701, USA
Jennifer Stanislaw: College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
Terri Warholak: College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
Nicole Scovis: Tabula Rasa HealthCare, Tucson, AZ 85701, USA
David R. Axon: College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA
Jacques Turgeon: Tabula Rasa HealthCare, Precision Pharmacotherapy Research and Development Institute, Orlando, FL 32827, USA
Srujitha Marupuru: College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA

IJERPH, 2021, vol. 18, issue 12, 1-7

Abstract: (1) Background: Regular contact with a medication therapy management (MTM) pharmacist is shown to improve patients’ understanding of their condition; however, continued demonstration of the value of a pharmacist delivered comprehensive medication review (CMR) using enhanced MTM services via telehealth is needed. The study aimed to describe a pilot program designed to improve type 2 diabetes mellitus (T2DM) management through enhanced condition specific MTM services. (2) Methods: This retrospective study included patients with T2DM aged 40–75 years who received a pharmacist-delivered CMR between January and December 2018. An evaluation of glycosylated hemoglobin (HbA1c) values 3 months pre- and post-CMR was performed. Wilcoxon signed-rank and chi-square tests were used. (3) Results: Of 444 eligible patients, a majority were female (58%) with a median age of 70 years. Median HbA1c values post-CMR were lower than pre-CMR (median 7.1% range 4.5–13.6; median 7.4% range 4.5–13.9, respectively; p = 0.009). There were fewer participants with HbA1c >9% post-CMR ( n = 66) than pre-CMR ( n = 80; p < 0.001) and more with HbA1C <6.5% post-CMR ( n = 151) than pre-CMR ( n = 130; p < 0.001). (4) Conclusion: This program evaluation highlighted the value of an enhanced condition specific MTM service via telehealth. Patients had improved HbA1c values three months after receiving a single pharmacist delivered CMR.

Keywords: type 2 diabetes; pharmacist; glycosylated hemoglobin; medication therapy management; comprehensive medication review; telehealth; T2DM (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/12/6560/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/12/6560/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:12:p:6560-:d:577269

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().